Chemical Biology: A sweet success
Nature Chemical Biology
2012년3월26일
A method for engineering a bacterial strain to create eukaryotic glycoproteins is presented this week in Nature Chemical Biology. These results may have immediate importance for industrial production of glycoproteins that scientists use in looking for therapies for various diseases.
Presently, glycoproteins needed for medical treatments and scientific research are created using hard-to-manipulate eukaryotic cells to retain the specific glycans which are critical for biological function: Eukaryotic glycoproteins are labeled with a specific sugar-rich carbohydrate sequence that determines the localization, function, and stability of the corresponding protein. Bacteria also attach carbohydrates to some of their proteins, but the sugar structure is significantly different from the eukaryotic glycoproteins created.
Matthew DeLisa and colleagues now create an engineered E. coli cell that can produce a five-carbohydrate chain - the ‘core structure’ of the eukaryotic carbohydrate sequence - that can be further attached to several eukaryotic proteins made in the same cell.
doi: 10.1038/nchembio.921
리서치 하이라이트
-
2월18일
Nature Energy Focus issue: How extreme weather events disrupt energy systemsNature Energy
-
1월28일
Materials science: Increased nuclear waste storage corrosion at material interfacesNature Materials
-
1월9일
Ecology: Reassessing impacts of ocean acidification on fish behaviourNature
-
12월20일
Marine biology: Acidified oceans may corrode shark scalesScientific Reports
-
12월19일
Anthropology: The final stand of Homo erectusNature
-
12월17일
Energy: Health and financial impacts of time-of-use energy rates raise equity concernsNature Energy
